Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
Eli Lilly’s weight-loss pill Foundayo won UK approval to treat both weight management and type 2 diabetes, making it the first European country to clear the drug for both indications.
Aug 17, 2026 ·
Yahoo Finance


















